Peptides
Explore the peptide library
Browse Mino's curated, educational peptide library, then build a sample protocol around your goals. A licensed physician finalizes everything with you — at $0 out of pocket.
The complete peptide portfolio.
35 pharmaceutical-grade peptide compounds — ≥99% purity, HPLC and MS verified — organized across 9 therapeutic categories, available through your DEA member benefit.
Weight Management
Incretin and adjunctive compounds for medical weight management, glycemic control, and body composition.
View compoundsRecovery & Healing
Compounds indicated in tissue repair, gastrointestinal healing, connective tissue recovery, and post-injury regeneration.
View compoundsImmune Stack
Compounds with documented roles in immune modulation, antimicrobial defense, and mucosal protection.
View compoundsLongevity & Cellular Health
Compounds studied in the context of cellular aging, mitochondrial function, telomere biology, and healthspan extension.
View compoundsGrowth Hormone Support
Compounds associated with growth hormone-axis modulation, recovery, lean tissue support, and healthy aging.
View compoundsSkin & Aesthetics
Compounds for dermal regeneration, collagen synthesis, hair restoration, and aesthetic practice.
View compoundsCognitive & Neurological
Compounds studied in the context of focus, memory, neuroprotection, anxiety, and cognitive performance.
View compoundsSexual Health Stack
Compounds for sexual function, desire, intimacy, and reproductive endocrinology research.
View compoundsSpecialty Peptides
Mitochondrial, neurorestorative, and exercise-mimetic compounds at the frontier of investigational practice.
View compoundsWeight Management
Incretin and adjunctive compounds for medical weight management, glycemic control, and body composition.
Weight management sits at the intersection of the most clinically validated and the most rapidly evolving segments of the peptide market. Incretin therapy has moved from endocrinology into mainstream primary care, aesthetic practice, and longevity medicine. Mino supplies both FDA-approved branded incretins where a legitimate dispensing pathway exists and a curated set of investigational multi-agonist compounds for qualified clinical and research settings. Regulatory status is disclosed at the compound level and again at the order level.
Medical weight management programs · Endocrinology-adjacent practices · Longevity and preventive medicine · Body composition and aesthetic optimization · Clinical research environments
Weight management compounds represent the most regulated segment of the portfolio. Mino maintains documented chain-of-custody for every lot and works exclusively with manufacturing partners whose facilities we have verified. Where a branded FDA-approved agent is not commercially viable, Mino supplies investigational multi-agonist compounds under research-use documentation.
GLP3-RT
Lyophilized vial
InvestigationalTriple GLP-1 / GIP / Glucagon receptor agonist for weight management research
The first triple incretin agonist class. Up to ~24% weight loss in Phase 2 trials — the highest efficacy ever recorded in the category. Adds direct fat oxidation via glucagon receptor activation on top of dual incretin appetite suppression.
Ideal for · Patients seeking maximum results; those who plateaued on dual agonists; advanced metabolic protocols
Tirzepatide
Lyophilized vial
FDA-approved (brand)Dual GLP-1 / GIP receptor agonist for weight management and glycemic control
The lead dual-pathway metabolic compound. Up to ~22.5% weight loss in clinical trials. Once-weekly injection with dual-pathway appetite reduction and superior glycemic control over single-pathway agonists.
Ideal for · BMI ≥27, Type 2 diabetes, metabolic syndrome, aesthetic weight loss
Cagrilintide
Lyophilized vial
InvestigationalLong-acting amylin analog, satiety and weight regulation
Acylated amylin analog with extended half-life. Targets satiety pathways distinct from GLP-1 — frequently combined with incretins in research protocols for additive weight loss without additional GI burden.
Ideal for · Stack add-on for incretin protocols; patients seeking non-incretin satiety support
AOD-9604
Lyophilized vial
Research useLipolytic fragment of human growth hormone
Modified HGH fragment (aa 177-191). Stimulates targeted lipolysis without growth-promoting or diabetogenic effects. No blood sugar impact. No IGF-1 elevation.
Ideal for · Patients who can't tolerate GLP-1s; athletes; targeted body composition
Recovery & Healing
Compounds indicated in tissue repair, gastrointestinal healing, connective tissue recovery, and post-injury regeneration.
Recovery and healing peptides are among the most clinically studied compounds in the portfolio, with substantial preclinical literature and growing human investigational data. BPC-157 and TB-500 have become cornerstones of integrative musculoskeletal protocols. ARA-290 has been investigated in tissue protection contexts. Mino supplies these primarily to orthopedic, integrative, and post-surgical care settings where documented sourcing matters as much as the clinical outcome.
Orthopedic and sports medicine practices · Integrative medicine clinics · Regenerative aesthetic practices · Post-surgical recovery programs · Gastroenterology support protocols
Lyophilized vials are shipped at ambient temperature and should be refrigerated upon receipt. Reconstituted product should be used within manufacturer-specified stability windows. All compounds ship with lot-specific storage documentation and a Certificate of Analysis from an independent testing laboratory.
BPC-157
Lyophilized vial
Research useGastrointestinal repair, tendon and ligament recovery
15-amino-acid gastric peptide with 100+ published studies. Accelerates healing of muscles, tendons, ligaments, nerves, and GI tract. Universal tissue repair with unmatched clinical depth.
Ideal for · Athletes, post-surgical, GI issues, tendon/ligament injuries — broadest appeal
TB-500
Lyophilized vial
Research useSoft tissue repair, inflammation modulation
43-amino-acid peptide (Thymosin Beta-4) promoting cell migration and blood vessel formation. Cardioprotective with documented hair follicle activation.
Ideal for · Slow-healing wounds, cardiac patients, hair thinning, musculoskeletal injuries
Wolverine (BPC-157 / TB-500)
Lyophilized vial
Research useCombined regenerative protocol — tissue repair stack
The two most widely used regenerative peptides co-formulated in a single vial. Synergy across soft tissue, GI, and connective tissue repair pathways — the de-facto standard recovery stack.
Ideal for · Post-surgical, orthopedic injury, complex soft-tissue cases needing both pathways
ARA-290
Lyophilized vial
InvestigationalTissue protection and small fiber neuropathy research
11-amino-acid erythropoietin-derived peptide retaining cytoprotective signaling without erythropoietic effect. Investigated for neuropathic pain, sarcoidosis, and inflammatory tissue injury.
Ideal for · Neuropathic pain protocols; inflammatory tissue injury; investigational settings
Immune Stack
Compounds with documented roles in immune modulation, antimicrobial defense, and mucosal protection.
The immune stack contains compounds at the intersection of antimicrobial defense, immune modulation, and mucosal repair. Thymosin-Alpha 1 has a regulatory history as an approved agent outside the United States and continues to be studied in immune-mediated conditions. LL-37 and KPV are research-use compounds with documented mechanisms in chronic infection and inflammatory disease contexts. VIP is supplied for investigational use in chronic inflammatory and biotoxin protocols.
Functional and integrative medicine · Chronic infection programs · Post-viral and chronic inflammatory care · Immune support adjuncts to oncology · Clinical research
Several compounds in this category are dispensed primarily into chronic-infection and complex-case practice settings. Mino clinical reference materials describe administration routes, dosing ranges in published literature, and stability considerations on a per-compound basis.
LL-37
Lyophilized vial
Research useAntimicrobial cathelicidin, immunomodulatory
Human cathelicidin with broad-spectrum antimicrobial activity. Disrupts biofilms at the source. A cornerstone of immune defense and wound healing.
Ideal for · Chronic infections, Lyme, biofilm conditions, immune-compromised, wound healing
KPV
Lyophilized vial
Research useAnti-inflammatory tripeptide, mucosal healing
Alpha-MSH derived tripeptide. Potent NF-kB inhibitor with oral bioavailability — particularly effective for gut inflammation.
Ideal for · IBD, Crohn's, UC, IBS, chronic inflammatory skin conditions, steroid alternatives
Thymosin-Alpha 1
Lyophilized vial
Research useImmune support, post-viral recovery protocols
28-amino-acid thymic peptide approved in 35+ countries. Enhances T-cell and NK cell function through immune modulation — not suppression. Decades of safety data.
Ideal for · Chronic infections, cancer immune support, Lyme, post-COVID, immune-compromised
VIP
Lyophilized vial
Research useVasoactive Intestinal Peptide, immune and inflammatory regulation
28-amino-acid neuropeptide with broad immunomodulatory activity. Dispensed primarily into chronic inflammatory response (CIRS) and biotoxin-illness protocols where downregulation of TGF-beta-1 and inflammatory cytokines is a clinical objective.
Ideal for · CIRS, mold-illness, chronic inflammatory protocols under specialist supervision
Longevity & Cellular Health
Compounds studied in the context of cellular aging, mitochondrial function, telomere biology, and healthspan extension.
Longevity medicine has emerged as one of the fastest-growing segments of private clinical practice. The compounds in this category are not approved for anti-aging indications, and we are explicit with our accounts that they are supplied for research and investigational use within appropriately structured clinical settings. The scientific rationale ranges from well-established mechanisms (NAD+ in mitochondrial bioenergetics) to early-stage hypotheses. Mino provides clinical reference material for each compound describing the current state of evidence — not marketing claims.
Longevity and preventive medicine practices · Functional medicine clinics · Concierge and executive health programs · Clinical research environments
Mino clinical reference documents cite primary literature where it exists and clearly label the distinction between preclinical findings, early human data, and established clinical outcomes.
NAD+
Lyophilized vial
Research useCellular energy and redox support
Essential coenzyme for energy production, DNA repair, and sirtuin activation. Endogenous levels decline ~50% by age 60. The gateway longevity compound.
Ideal for · Anyone over 35; fatigue; brain fog; athletes; metabolic patients
MOTS-C
Lyophilized vial
Research useMitochondrial-derived peptide, metabolic regulation
Mitochondrial-encoded peptide activating AMPK — the same pathway as exercise. Improves insulin sensitivity and fat oxidation at the cellular level.
Ideal for · Longevity patients; those who can't exercise; metabolic optimization; athletes
5-Amino-1MQ
Oral capsule
Research useNNMT inhibitor under investigation for metabolic and longevity modulation
Oral NNMT inhibitor blocking the fat-storage enzyme while boosting intracellular NAD+. No injection required — a rare oral option in the longevity category.
Ideal for · Injection-averse patients; biohackers; add-on to injectable protocols
Epithalon
Lyophilized vial
Research useTelomerase activation, pineal-axis research
Synthetic tetrapeptide activating telomerase and maintaining telomere length. Regulates the melatonin-cortisol cycle. Decades of gerontological research.
Ideal for · Longevity-focused patients; sleep issues; the optimization community
Growth Hormone Support
Compounds associated with growth hormone-axis modulation, recovery, lean tissue support, and healthy aging.
Growth hormone-axis peptides have a long history of use in integrative and sports medicine contexts. They are among the most clinically familiar peptides in practice, with decades of prescribing experience behind them. Mino emphasizes that these compounds are supplied to credentialed practitioners operating within legitimate medical frameworks, not for direct athletic enhancement. Sermorelin and Tesamorelin carry FDA approval for specific indications.
Integrative medicine · Anti-aging and hormone optimization practices · Sports medicine and recovery protocols · Longevity clinics
Accounts serving athletic populations should be aware of sport-governing-body restrictions on growth hormone-axis compounds. Mino does not supply compounds intended to circumvent competitive sport regulations.
CJC-1295
Lyophilized vial
Research useLong-acting GHRH analog
Modified GHRH with an extended half-life (DAC variant) producing a sustained, physiologic GH pulse. Almost universally paired with a GHRP such as Ipamorelin.
Ideal for · Standard GH optimization protocols; pairs with Ipamorelin
Ipamorelin
Lyophilized vial
Research useSelective GH secretagogue
The cleanest GH release of any GHRP — no cortisol, prolactin, or appetite spikes. Almost universally paired with CJC-1295.
Ideal for · Standard GH optimization pairing with CJC-1295
CJC-1295 / Ipamorelin
Lyophilized vial
Research useCo-formulated GHRH + GHRP combination, body composition
The two most clinically familiar growth hormone secretagogues co-formulated in a single vial. Simplifies the standard stack and reduces injection burden.
Ideal for · Patients on the standard GH optimization stack; simplifying compliance
Tesamorelin
Lyophilized vial
FDA-approved (brand)GHRH analog — visceral adiposity and metabolic health
The only FDA-approved GH secretagogue (Egrifta). Clinically proven visceral fat reduction with documented cognitive benefits. Premium positioning.
Ideal for · Visceral adiposity; patients wanting an FDA-backed compound; premium tier
Hexarelin
Lyophilized vial
Research usePotent GH secretagogue, cardiac research
Strongest GH-releasing peptide of the GHRP family by potency. Cardioprotective signaling distinct from the GH axis itself. Used selectively where high pulse magnitude is the clinical objective.
Ideal for · Selective GH-secretagogue protocols where Ipamorelin is insufficient
Sermorelin
Lyophilized vial
FDA-approved (brand)GHRH analog, growth hormone support protocols
The original FDA-approved GHRH analog. The most clinically familiar option for restoring physiologic GH pulsatility in adult deficiency contexts.
Ideal for · Adult GH-axis support; entry-tier protocols; well-documented safety profile
Skin & Aesthetics
Compounds for dermal regeneration, collagen synthesis, hair restoration, and aesthetic practice.
Skin and aesthetic peptides are the largest volume segment of Mino's enterprise medical spa business. The category spans cellular signaling compounds (GHK-CU) with deep dermatologic literature, combination aesthetic blends, and melanocortin agonists supplied under research-use documentation. Each sub-segment has its own regulatory framework, and Mino maintains that distinction carefully in both catalog and sales practice.
Medical spas and aesthetic practices · Dermatology adjacencies · Hair restoration clinics · Post-procedure recovery programs
The skin and aesthetics category, together with recovery and healing, represents the largest volume segment of Mino's enterprise medical spa business. Tiered pricing is structured to reward consolidated ordering across categories.
GHK-CU
Lyophilized vial
Research useDermal regeneration, collagen synthesis, wound healing
Natural tripeptide-copper complex activating over 4,000 repair genes. Stimulates Collagen I & III synthesis. Injectable or topical (microneedling). The most validated aesthetic peptide available.
Ideal for · Skin rejuvenation, post-procedure recovery, hair restoration, anti-aging
GLOW
Lyophilized vial
Research useAesthetic combination protocol — skin radiance and recovery
Curated multi-peptide aesthetic blend designed for skin tone, texture, and post-procedure recovery. Dispensed primarily into med-spa practice for cycle-based aesthetic protocols.
Ideal for · Med-spa cycle programs; post-procedure recovery; aesthetic maintenance
Melanotan-1
Lyophilized vial
Research useMelanocortin-1 receptor agonist research
Selective alpha-MSH analog with greater MC1 receptor selectivity than Melanotan-2. Studied in photoprotection contexts and erythropoietic protoporphyria. Requires dermatologic monitoring and informed consent.
Ideal for · Photoprotection research; UV-sensitive patients; specialist supervision
Melanotan-2
Lyophilized vial
Research useBroad melanocortin receptor research
Alpha-MSH analog stimulating melanogenesis for enhanced tanning with reduced UV exposure. Broader receptor activity than Melanotan-1. Requires dermatologic monitoring and informed consent.
Ideal for · Fair-skinned patients; tanning with reduced sun exposure — consent required
Cognitive & Neurological
Compounds studied in the context of focus, memory, neuroprotection, anxiety, and cognitive performance.
The cognitive and neurological category contains compounds with neurological research literature ranging from well-established (Semax in nootropic and post-stroke recovery research outside the U.S.) to emerging (Selank in anxiolytic research). Mino supplies these primarily to functional neurology and integrative psychiatry settings operating under investigational frameworks. None of these compounds carry FDA approval for cognitive enhancement indications. Clinical reference materials describe the evidence base honestly.
Functional neurology · Integrative psychiatry · Concussion and TBI recovery programs · Longevity and cognitive wellness practices
Compounds in this category are commonly administered intranasally, which requires appropriate carrier formulation and patient education. Mino clinical reference materials include administration protocols by compound.
Selank
Nasal / intranasal
Research useAnxiolytic peptide, GABA modulation research
Tuftsin analog with GABAergic anxiolytic properties. Anxiety reduction without sedation or dependence. Approved in Russia for generalized anxiety disorder.
Ideal for · Anxiety patients (non-benzo option); SSRI alternatives; complement to Semax
Semax
Nasal / intranasal
Research useNootropic, neuroprotection research
The most popular nootropic peptide in clinical practice. A potent BDNF booster enhancing memory, focus, and learning with neuroprotective effects. Approved in Russia. Fast-acting.
Ideal for · Executives; professionals; cognitive decline; post-stroke; TBI; students
Sexual Health Stack
Compounds for sexual function, desire, intimacy, and reproductive endocrinology research.
The sexual health stack contains compounds operating across distinct biological pathways — central melanocortin signaling (PT-141), oxytocinergic signaling (Oxytocin), and upstream hypothalamic-pituitary-gonadal regulation (Kisspeptin). Each addresses a different axis of sexual function and intimacy. PT-141 carries FDA approval as a branded agent. Kisspeptin is supplied under research-use documentation for reproductive endocrinology and IVF research contexts.
Sexual health and intimacy practices · Reproductive endocrinology · Hormone optimization · Couples-medicine programs
Mino expects accounts to provide appropriate informed-consent and counseling around sexual health peptides. Reference materials include patient-facing summaries written for clinical handoff.
Oxytocin
Lyophilized vial
FDA-approved (brand)Bonding, intimacy, and stress-response research
Endogenous nonapeptide central to bonding, trust, and pair-bond signaling. Used in sublingual and intranasal protocols outside its FDA-approved obstetric indication.
Ideal for · Intimacy and couples-medicine protocols; stress-response support
PT-141
Injectable / nasal
FDA-approved (brand)Sexual function, melanocortin agonist
FDA-approved (Vyleesi). Works on the brain's desire pathway — not blood flow. Effective in both men and women. Fundamentally different mechanism than PDE5 inhibitors.
Ideal for · Female HSDD; male ED non-responders to Viagra/Cialis; desire enhancement
KISSPeptin
Lyophilized vial
Research useHPG-axis research, reproductive endocrinology
The upstream regulator of the entire reproductive axis. Triggers GnRH, LH/FSH, and downstream sex steroid production. In IVF: investigated to eliminate ovarian hyperstimulation syndrome.
Ideal for · Hypothalamic dysfunction; fertility; natural hormone optimization; IVF
Specialty Peptides
Mitochondrial, neurorestorative, and exercise-mimetic compounds at the frontier of investigational practice.
The specialty category contains compounds whose mechanisms are individually distinct and whose use is concentrated in advanced functional, longevity, and research practice. Several of these compounds are at the frontier of human investigational use — SS-31 in mitochondrial bioenergetics, SLU-PP-332 in exercise-mimetic research, Pinealon in neurorestorative bioregulator research. Mino supplies these under research-use documentation with full clinical reference materials.
Advanced longevity and functional medicine · Mitochondrial research practices · Sleep and circadian medicine · Investigational research environments
Specialty compounds are typically dispensed into single-specialist or research-program contexts rather than general practice. Many are categorized as Special Order; account managers can confirm lead times and minimum order quantities at the SKU level.
SS-31
Lyophilized vial
InvestigationalMitochondrial-targeted peptide, bioenergetics
Cell-permeable tetrapeptide (Elamipretide) stabilizing cardiolipin in mitochondrial membranes — restoring energy production at the structural level. Investigated in cardiac, ophthalmologic, and primary mitochondrial disease contexts.
Ideal for · Longevity patients; cardiac patients; fatigue; age-related decline
DSIP
Lyophilized vial
Research useDelta Sleep-Inducing Peptide, sleep architecture research
Nine-amino-acid peptide investigated in sleep architecture, stress modulation, and chronic-pain contexts. Dispensed into sleep-medicine research and integrative-psychiatry settings.
Ideal for · Sleep architecture protocols; stress-axis modulation; chronic-pain research
SLU-PP-332
Lyophilized vial
Research useERR-agonist, exercise-mimetic research
Estrogen-related receptor agonist investigated as an exercise mimetic — activating mitochondrial biogenesis and fat oxidation pathways normally engaged by endurance training. One of the most discussed compounds at the frontier of metabolic research.
Ideal for · Investigational exercise-mimetic protocols; metabolic research; advanced longevity
Pinealon
Lyophilized vial
Research useNeurorestorative bioregulator, cognitive research
Tripeptide bioregulator from the Khavinson school of peptide research. Investigated in neurorestorative, sleep-circadian, and age-related cognitive contexts.
Ideal for · Cognitive and neurorestorative research protocols; circadian-axis support
Build a sample protocol
Answer two quick questions and we'll assemble a starting point from the library above.
- 1Goals
- 2Experience
- 3Protocol
Step 1 of 3
What are your goals?
Choose one or more. Your selections shape a sample protocol you can review with a Mino MD.